Please assess the completion status of the following clinical trial:

Trial Title: Efficacy of Monthly Ibandronate in Women With RA and Reduced Bone Mineral Density Receiving Long-term Steroids

Study Design Characteristics:
- Allocation: RANDOMIZED
- Intervention Model: PARALLEL
- Observational Model: None
- Primary Purpose: PREVENTION
- Time Perspective: None
- Masking: QUADRUPLE
- Phase: PHASE4
- Number of Arms: 2.0

Eligibility Criteria:
Inclusion Criteria:~* Rheumatoid arthritis fulfilling the 1987 ACR criteria~* Women equal and above 18 years, less than 75 years old~* L1-4 T score less than -1.0 and equal or above -3.0 SD measured by DXA (Dual Energy X-ray Absorptiometry)~* Patient must have taken prednisolone 5mg or its equivalent for more than 3 consecutive months within 1 year~* Patient who would be taking glucocorticoids for more than 3 months after enrollment~Exclusion Criteria:~* Patient with vertebral fractures or nonvertebral fractures associated with osteoporosis~* Patient diagnosed with malignancy within 5 years~* Patient with endocrine dysfunction~* RA functional class 4~* Patient who took bisphosphonates within 6 months~* Patient on medication affecting bone mineral metabolism

- Gender: FEMALE
- Minimum Age: 18 Years
- Maximum Age: 75 Years
- Healthy Volunteers: f

Study Arms:
- Ibandronate treatment (Type: EXPERIMENTAL): Ibandronate 150mg PO once every 4 weeks
- Placebo arm (Type: PLACEBO_COMPARATOR): Placebo PO once every 4 weeks

Based on this trial design, predict the completion outcome and termination type (if applicable).